6/17/2023 Flashcards
Avelox
Moxifloxacin
Moxifloxacin MOA
Inhibits DNA gyrase, the enzyme that maintains the superhelical structure of DNA. Therefore, the drug inhibits DNA replication and transcription, DNA repair, recombination, and transposition.
Moxifloxacin class
Fluoroquinolone
CellCept
Mycophenolate
Mycophenolate class
immunosuppressant; antiproliferative agent
Mycophenolate MOA
Inhibitor of IMPDH, which is an enzyme responsible for cell proliferation, specific to B and T cells
Vivitrol
Naltrexone
Naltrexone MOA
Opioid antagonist - similar in structure to naloxone. Competitive antagonist against opioid receptor sites, shows highest affinity for mu receptors. Endogenous opioids are involved in modulating the expression of alcohol’s reinforcing effects.
Also modifies the HPA axis to suppress alcohol consumption.
Naproxen MOA
COX inhibition (non-selective); decreases prostaglandin synthesis
Macrobid
Nitrofurantoin
Nitrofurantoin MOA
Reduced by bacteria flavoproteins to reactivate intermediates and inactivate or alter bacterial ribosomal proteins, leading to inhibition of protein synthesis, aerobic energy metabolism, DNA, RNA, and cell wall synthesis.
Opdivo
Nivolumab
Nivolumab MOA
Monoclonal antibody that selectively inhibits programmed cell death-1 (PD-1) activity by binding to PD-1 receptor and blocking the ligands PDL-1 and PDL-2 from binding. Results in reversal of T-cell suppression and induction of immune antitumor responses.
Pamelor
Notriptyline
Nortriptyline MOA
Inhibits reuptake of serotonin and norepinephrine in the CNS. Also inhibits activity of histamine and acetylcholine.
Nivolumab class
Anti-PD-1 monoclonal antibody (antineoplastic)
Nortriptyline class
tricyclic antidepressant
Bio-Statin
Nystatin
Nystatin MOA
Binds to sterols in the fungal cell membrane, changing the cell wall permeability and allowing for leakage of cellular contents.
Nystatin class
antifungal
Gazyva
Obinutuzumab
Obinutuzumab MOA
monoclonal antibody that targets CD20 antigen on B-cells and mediates cell lysis
Obinutuzumab class
Anti-CD20 antineoplastic agent
Ocrevus
Ocrelizumab
Ocrelizumab MOA
Monoclonal antibody directed against CD-20 expressing B cells, leading to cell-mediated phagocytosis and cytotoxicity. Less B cells leads to less production of autoantibodies and cytokines responsible for damage to myelin.
Ocrelizumab class
Anti-CD20 monoclonal antibody
Sandostatin
Octreotide
Octreotide MOA
Mimics natural somatostatin by inhibiting serotonin release and the secretion of gastrin, VIP, insulin, glucagon, secretin, motilin, and pancreatic polypeptide.
Octreotide class
Antidiarrheal; somatostatin analog
Arzerra
Ofatumumab
Ofatumumab MOA
Monoclonal antibody against CD20 on B cells, resulting in B cell lysis and antibody-dependent cell-mediated toxicity in cells that overexpress CD20.